Category1 Category2 Category3

Roivant Sciences, a three-year-old, Basel, Switzerland-based company aiming to one day be a giant holding company for dozens of independent biopharmaceutical companies, has raised $1.1 billion in equity led by the SoftBank Vision Fund â€” making it the latest in a string of enormous bets by SoftBank, and putting the young outfit more squarely on the radar of the tech world.

ID:http://techcrunch.com/?p=1525027_0